Division of Psychiatry and Applied Psychology, University of Nottingham, Nottingham, UK.
Institute of Mental Health, Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK.
F1000Res. 2020 Apr 7;9:242. doi: 10.12688/f1000research.22880.2. eCollection 2020.
: Post-stroke fatigue (PSF) is one of the most common and frustrating outcomes of stroke. It has a high prevalence and it can persist for many years after stroke. PSF itself contributes to a wider range of undesirable outcomes that affect all aspects of daily life. The aim of this review was to identify and summarise the most recent research on PSF, in order to update the evidence base. : We updated an existing review (Hinkle . 2017) systematically searching CINAHL, MEDLINE, PsycINFO, and PubMed to cover new research studies between 1 March 2016 and the search date (19 January 2020). We included interventional and observational research, and clinical practice guidelines that were not covered in the original review. After duplicate removal in EndNote, two reviewers screened the search results in Rayyan, and data from eligible full texts were extracted onto an Excel spreadsheet. Finally, we used RobotReviewer and a human reviewer to assess the risk of bias of randomised trials for this scoping review. : We identified 45 records for 30 studies (14 observational, 10 interventional studies, and 6 guidelines). Apart from one, the interventional studies were single-centred, had high risk of bias and small sample size (median 50). They investigated exercise, pharmacotherapy, psychotherapy, education, and light therapy. Observational studies mainly reported the factors related to PSF including co-morbidities, depression and anxiety, quality of life, activities of daily living, stroke severity, medication use and polypharmacy, polymorphism, pain, apathy, limb heaviness, neuroticism, mobility, and thyroid-stimulating hormone. Guidelines either did not report on PSF or, when reported, their recommendations were supported by little or low level of evidence. : Although we identified a number of recent studies which have added to our current knowledge on PSF, none are robust enough to change current clinical practice.
卒中后疲劳(PSF)是卒中后最常见和最令人沮丧的后果之一。它的发病率很高,并且在卒中后可能持续多年。PSF 本身会导致更广泛的不良后果,影响日常生活的各个方面。本综述的目的是确定和总结 PSF 的最新研究,以更新证据基础。
我们系统地更新了现有的综述(Hinkle,2017 年),在 CINAHL、MEDLINE、PsycINFO 和 PubMed 中进行了搜索,以涵盖 2016 年 3 月 1 日至搜索日期(2020 年 1 月 19 日)之间的新研究。我们纳入了干预性和观察性研究,以及原始综述未涵盖的临床实践指南。在 EndNote 中去除重复项后,两名审查员在 Rayyan 中筛选搜索结果,将合格的全文数据提取到 Excel 电子表格中。最后,我们使用 RobotReviewer 和人工审查员对这一范围综述的随机试验偏倚风险进行评估。
我们确定了 30 项研究的 45 条记录(14 项观察性研究,10 项干预性研究和 6 项指南)。除了一项研究外,干预性研究均为单中心研究,偏倚风险高,样本量小(中位数 50)。它们研究了运动、药物治疗、心理治疗、教育和光疗。观察性研究主要报告了与 PSF 相关的因素,包括合并症、抑郁和焦虑、生活质量、日常生活活动、卒中严重程度、药物使用和药物滥用、多态性、疼痛、冷漠、肢体沉重、神经质、活动能力和促甲状腺激素。指南要么没有报告 PSF,要么报告了 PSF,但推荐意见的依据是证据很少或很低。
尽管我们确定了一些最近的研究,这些研究增加了我们对 PSF 的现有认识,但没有一项研究足够强大,可以改变当前的临床实践。